Literature DB >> 19626402

Treatment strategy and clinical outcome in Japanese patients with atrial fibrillation.

Shinya Suzuki1, Takeshi Yamashita, Takayuki Otsuka, Koichi Sagara, Tokuhisa Uejima, Yuji Oikawa, Junji Yajima, Akira Koike, Kazuyuki Nagashima, Hajime Kirigaya, Ken Ogasawara, Hitoshi Sawada, Tsutomu Yamazaki, Tadanori Aizawa.   

Abstract

Many large-scale randomized control trials (RCTs) have been performed regarding treatment strategy in atrial fibrillation (AF) in Western countries and also in Japan. However, limited data are available concerning real-world relationships between the treatment strategy and prognosis of AF patients. Out of a prospective cohort of The Shinken Database 2004 (n = 2 412), 286 AF patients (male 205, 64.1 +/- 12.3 years, paroxysmal form 165) were retrospectively investigated. The percentage of AF patients under the rhythm control strategy was evaluated using the Kaplan-Meier method, which showed the cumulative proportion of rhythm control strategy was approximately 30% at the 90th day after the initial visit and 40.0% at 1 year. The average time to the first rhythm control strategy was 68.3 +/- 106.7 days. Those under rhythm control strategy were associated with fewer coexisting organic cardiac diseases, a younger age, and smaller left atrial dimension. Consequently, they showed very good prognosis (cumulative incidence rate of cardiovascular events at 1 year was 0.0%). Careful induction of rhythm control strategy, which was adopted in approximately 40% of the patients in the real world, was associated with fewer comorbidities and therefore might lead to better prognosis, although this does not mean the direct effects of rhythm control strategy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626402     DOI: 10.1007/s00380-008-1121-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  13 in total

Review 1.  Atrial fibrillation.

Authors:  R H Falk
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

4.  Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?

Authors:  Dariusz A Kosior; Marcin Szulc; Grzegorz Opolski; Adam Torbicki; Daniel Rabczenko
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

5.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

6.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

7.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

8.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004.

Authors:  Shinya Suzuki; Takeshi Yamashita; Takayuki Ohtsuka; Koichi Sagara; Tokuhisa Uejima; Yuji Oikawa; Junji Yajima; Akira Koike; Kazuyuki Nagashima; Hajime Kirigaya; Ken Ogasawara; Hitoshi Sawada; Tadanori Aizawa
Journal:  Circ J       Date:  2008-06       Impact factor: 2.993

10.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272

View more
  12 in total

1.  Different strategies for performing pulmonary vein isolation in patients with pulmonary vein rhythm.

Authors:  Michifumi Tokuda; Teiichi Yamane; Seiichiro Matsuo; Keiichi Ito; Ryohsuke Narui; Mika Hioki; Shin-Ichi Tanigawa; Tokiko Nakane; Seigo Yamashita; Keiichi Inada; Kenri Shibayama; Satoru Miyanaga; Hiroshi Yoshida; Hidekazu Miyazaki; Taro Date; Ken-Ichi Sugimoto; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2011-01-28       Impact factor: 2.037

2.  Diverse cell morphology and intracellular calcium dynamics in pulmonary vein cardiomyocytes.

Authors:  Ming-Chih Yu; Chun-Feng Huang; Che-Ming Chang; Yao-Chang Chen; Cheng-I Lin; Shih-Ann Chen
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

3.  Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects.

Authors:  Tsuyoshi Shiga; Takanori Tanaka; Shin Irie; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

4.  Rapid ventricular pacing: a fast, reliable, and safe technique for optimization of image acquisition during rotational angiography for catheter ablation of atrial fibrillation.

Authors:  Sebastian Hilbert; Nikolaos Dagres; Gerhard Hindricks; Philipp Sommer; Thomas Gaspar; Loukianos S Rallidis; Dimitrios Th Kremastinos; Christopher Piorkowski
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

5.  Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Naokata Sumitomo; Takahiro Nakamura; Junji Fukuhara; Toshiko Nakai; Ichiro Watanabe; Hideo Mugishima; Masayasu Hiraoka
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

6.  Relation of gender and interatrial dyssynchrony on tissue Doppler imaging to the prediction of the progression to chronic atrial fibrillation in patients with nonvalvular paroxysmal atrial fibrillation.

Authors:  Koichi Sakabe; Nobuo Fukuda; Yamato Fukuda; Satofumi Morishita; Hisanori Shinohara; Yoshiyuki Tamura
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

7.  No severe pulmonary vein stenosis after extensive encircling pulmonary vein isolation: 12-month follow-up with 3D computed tomography.

Authors:  Shingo Maeda; Yoshito Iesaka; Kiyoshi Otomo; Kikuya Uno; Yasutoshi Nagata; Kenji Suzuki; Hitoshi Hachiya; Masahiko Goya; Atsushi Takahashi; Hideomi Fujiwara; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2010-12-04       Impact factor: 2.037

8.  Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome.

Authors:  Yasutsugu Nagamoto; Tomohito Inage; Teruhisa Yoshida; Tomohiro Takeuchi; Takeki Gondo; Yujiro Fukuda; Eiichi Takii; Kenta Murotani; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2011-04-20       Impact factor: 2.037

9.  Long-term results of the maze procedure on left ventricular function for persistent atrial fibrillation associated with mitral valve disease.

Authors:  Yujiro Fukuda; Teruhisa Yoshida; Tomohito Inage; Tomohiro Takeuchi; Takeki Gondo; Eiichi Takii; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2011-02-18       Impact factor: 2.037

10.  Catheter ablation of persistent atrial fibrillation in a patient with cor triatriatum sinister demonstrating a total common trunk of the pulmonary vein.

Authors:  Michifumi Tokuda; Teiichi Yamane; Kenichi Tokutake; Kenichi Yokoyama; Mika Hioki; Ryohsuke Narui; Shin-Ichi Tanigawa; Seigo Yamashita; Keiichi Inada; Seiichiro Matsuo; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2014-09-12       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.